CGB7 and urothelial carcinoma: Kaplan-Meier survival analyses elucidate an association between CGB7 expression and decreased survival probability in a cohort of advanced urothelial carcinoma patients treated with PD-L1 inhibition immunotherapy, which is supported by an association between CGB7 expression and progressive disease in this cohort.